The Third COVID Vaccine Has Just Entered into the Market!

What do we need to know about the Johnson & Johnson vaccine?

Johnson & Johnson vaccine is the third American COVID vaccine that has entered into the market!

On Monday March 1st, the first truckload of Johnson and Johnson (J&J) vaccine arrived at the worldwide distribution center of the UPS in Louisville, Kentucky. This marked the day 1 of the entry of the 3rd American COVID vaccine into the market. In this blog my main goal is to highlight the outstanding features of the J&J vaccine and to compare and contrast it with the Moderna and Pfizer vaccines.

The Cardinal Contrasts

The J&J vaccine is contrasted with Moderna and Pfizer vaccines in four important respects:

  1. It is a DNA and not an RNA vaccine. This makes a major part of its interaction with our cellular machinery different from the Moderna and Pfizer vaccines.
  2. It is a single-jab and not a two-jab vaccine. This makes the use of it more convenient for the recipients.
  3. It is more stable in higher temperatures and it can be stored in the refrigerators instead of the freezers. This makes the challenge of transportation and storage of it more convenient and practical.
  4. It uses a different mechanism of entry into the cells that sets it apart from the other two American vaccines  and makes it similar to AstraZeneca vaccine that has been primarily used in the United Kingdom. 

You need to login to view the rest of the content. Please Login.
Not a Member? Sign up for free!

Dr. Eftekar (Dr. E) is the founder and head coach of the Center for Conquest of Longevity and Northwestern Medical Review. A unique attribute of Dr. E is his well-rounded academic background that, in addition to the science of medicine, extends over several other disciplines such as physiology of aging and longevity, philosophy of science and medicine, and integrated kinesiology.

Write a comment